Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-24 @ 6:18 PM
Study NCT ID:
NCT01797120
Status:
COMPLETED
Last Update Posted:
2018-05-30
First Post:
2013-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Sponsor:
PrECOG, LLC.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PrE0102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |